Wednesday, June 15, 2011 2:14:21 AM
There are other methods of genetic modification (GM) but they are totally unusable for the purpose of modifying silkworms to produced spider silk. The reason is that they are far more random in their insertions than the piggyBac transposon (which is itself random but far less so) and especially zinc fingers which are completely exact.)
It requires the insertion of many genes to get silkworms to make spider silk (that's why it took KBLB so long to do what it did with the piggyBac transposon. Even then the piggyBac just couldn't do the job because the silkworm silk protein genes needed to be removed (their continued presence was why the Gen1 worms had worm silk protein mixed in with the spider silk protein) Each gene has to be placed in a suitable location (the location determines what tissue it's expressed in and under what circumstances it is expressed).
Other methods of GM are so random that the overwhelming majority of insertions won't work because random placement puts them where they are not expressed at all, or in the wrong tissue, or under the wrong circumstances or kill the organism by being inserted into a gene and disabling that gene. It's very hard to get them to work on installing just one GM. If they have to do a whole set of them they become completely impractical.
So exclusive rights to the use of zinc fingers and the piggyBac for that purpose constitutes real and effective protection of KBLB's technology.
In addition KBLB holds exclusive rights to over 200 spider genes, all related to silk production. That is a second very strong protection to KBLB's technology. Where would anyone get the genes for spider silk production if not from a spider?
Recent KBLB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 11/05/2024 12:00:04 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM